Jayshree Chemicals Ltd files un‑audited financial results for Q1 FY2026

What Jayshree Chemicals announced

Jayshree Chemicals Ltd (BSE: 506520) submitted its unaudited financial results for the quarter ended 30 June 2026. The submission, made on 16 July 2026, is accompanied by a Limited Review Report prepared by AMK & Associates, the firm that serves as the company’s statutory auditor. The filing does not contain any detailed financial figures such as revenue, profit or earnings per share.

Limited Review Report by AMK & Associates

A Limited Review is a statutory engagement that provides a moderate level of assurance that the financial statements are free from material misstatement. Unlike a full audit, the review does not involve extensive testing of transactions or internal controls. AMK & Associates, as the statutory auditor, issued the review report concurrently with the unaudited results, confirming that the statements have been examined in accordance with the applicable standards for a limited review.

Key facts at a glance

Why this matters for investors

The filing satisfies the regulatory requirement for listed companies to disclose quarterly financial performance, even when the results are unaudited. A limited review provides a degree of assurance, but investors should note that the figures have not undergone a full audit. The absence of disclosed numbers means that shareholders cannot assess the company’s operational performance for the quarter from this filing alone. Any subsequent audited results or management commentary will be needed for a complete evaluation.

Conclusion

Jayshree Chemicals Ltd has complied with its disclosure obligations by filing unaudited Q1 FY2026 results together with a Limited Review Report from AMK & Associates on 16 July 2026. While the filing confirms that the financial statements have been reviewed, it does not reveal any quantitative performance metrics. Investors will need to await further disclosures, such as audited results or detailed management discussion, to gauge the company’s financial health for the quarter.